- Sections
- C - Chimiemétallurgie
- C07C - Composés acycliques ou carbocycliques
- C07C 311/47 - Y étant un hétéro-atome
Détention brevets de la classe C07C 311/47
Brevets de cette classe: 34
Historique des publications depuis 10 ans
|
1
|
6
|
5
|
2
|
3
|
1
|
0
|
0
|
0
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Northwestern University | 3403 |
3 |
| Syngenta Limited | 454 |
2 |
| The General Hospital Corporation | 4751 |
2 |
| Fudan University | 689 |
2 |
| Nippon Soda Co., Ltd. | 895 |
2 |
| Papierfabrik August Koehler SE | 45 |
2 |
| Welichem Biotech Inc. | 5 |
2 |
| Novartis AG | 10727 |
1 |
| Bristol-myers Squibb Company | 4872 |
1 |
| The Regents of the University of California | 20015 |
1 |
| Merck Sharp & Dohme Corp. | 2191 |
1 |
| Arete Therapeutics, Inc. | 23 |
1 |
| Griffith University | 155 |
1 |
| Helsinn Healthcare SA | 229 |
1 |
| Immunomet Therapeutics Inc. | 31 |
1 |
| The Jackson Laboratory | 346 |
1 |
| Metasignal Therapeutics Inc. | 3 |
1 |
| Novartis Pharma GmbH | 116 |
1 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 165 |
1 |
| Shifa Biomedical Corporation | 17 |
1 |
| Autres propriétaires | 6 |